Associate Professor
The University of Texas at Austin
San Antonio, TX, United States
Dr. Kelly Reveles is an Associate Professor at The University of Texas at Austin College of Pharmacy and an Adjoint Associate Professor at The University of Texas Health Science Center at San Antonio School of Medicine. She received her Doctor of Pharmacy and Translational Science PhD degrees from UT Austin. Her current research focuses on the prevention and treatment of Clostridioides difficile infections and innovative methods to improve the translation of clinical research findings into practice. Her research approach emphasizes multidisciplinary, collaborative research across the translational spectrum, including basic science, preclinical animal studies, human clinical studies, and pharmacoepidemiology studies. She is specifically interested in identifying and implementing clinical strategies for the prevention and treatment of C. difficile infection using national data, the impact of drugs and diseases on the gut microbiome, and the development of microbiome-targeted therapies to mitigate these effects. She has published over 100 peer-reviewed papers and has been awarded over $5 million in federal grants to support her research.
Disclosure(s): AstraZeneca: Grant/Research Support (Ongoing); Ferring Pharmaceuticals Inc.: Advisor/Consultant (Ongoing), Honoraria (Ongoing)
Friday, October 18, 2024
3:15 PM – 4:30 PM US PT
436 - Fidaxomicin isn't necessary with Vancomycin and Bezlotuxumab: Pro
Friday, October 18, 2024
3:15 PM – 3:33 PM US PT